A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells.

[1]  E. Knudsen,et al.  Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure , 2010, Oncogene.

[2]  M. Barbacid,et al.  A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma. , 2010, Cancer cell.

[3]  P. Deloukas,et al.  Signatures of mutation and selection in the cancer genome , 2010, Nature.

[4]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[5]  N. Hay,et al.  FoxM1, a critical regulator of oxidative stress during oncogenesis , 2009, The EMBO journal.

[6]  J. Hartman,et al.  FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. , 2009, International journal of oncology.

[7]  S. Haferkamp,et al.  p16INK4a-induced senescence is disabled by melanoma-associated mutations , 2008, Aging cell.

[8]  R. Medema,et al.  FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner , 2008, Cell cycle.

[9]  A. Tyner,et al.  FoxM1 Regulates Transcription of JNK1 to Promote the G1/S Transition and Tumor Cell Invasiveness* , 2008, Journal of Biological Chemistry.

[10]  S. Mohammed,et al.  Activation of FoxM1 during G2 Requires Cyclin A/Cdk-Dependent Relief of Autorepression by the FoxM1 N-Terminal Domain , 2008, Molecular and Cellular Biology.

[11]  Douglas S. Darling,et al.  Zeb1 links epithelial-mesenchymal transition and cellular senescence , 2008, Development.

[12]  S. Mohammed,et al.  Activation of FoxM 1 during G 2 Requires Cyclin A / Cdk-Dependent Relief of Autorepression by the FoxM 1 N-Terminal Domain † , 2008 .

[13]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[14]  Dean W. Felsher,et al.  Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation , 2007, Proceedings of the National Academy of Sciences.

[15]  G. Peters,et al.  CDK4 and CDK6 Delay Senescence by Kinase-Dependent and p16INK4a-Independent Mechanisms , 2007, Molecular and Cellular Biology.

[16]  Amanda M. Ackermann,et al.  Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. , 2007, Journal of molecular endocrinology.

[17]  Raymond Sawaya,et al.  FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. , 2006, Cancer research.

[18]  B. Lüscher,et al.  Regulation of the transcription factor FOXM1c by Cyclin E/CDK2 , 2006, FEBS letters.

[19]  I. Wierstra,et al.  Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4 , 2006, Biological chemistry.

[20]  Yan Geng,et al.  Requirement for CDK4 kinase function in breast cancer. , 2006, Cancer cell.

[21]  Tiansen Li,et al.  Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. , 2006, Cancer cell.

[22]  Vladimir Petrovic,et al.  Forkhead Box M1 Regulates the Transcriptional Network of Genes Essential for Mitotic Progression and Genes Encoding the SCF (Skp2-Cks1) Ubiquitin Ligase , 2005, Molecular and Cellular Biology.

[23]  T. Golub,et al.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.

[24]  Hans Clevers,et al.  FoxM1 is required for execution of the mitotic programme and chromosome stability , 2005, Nature Cell Biology.

[25]  N. Pryer,et al.  Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. , 2004, Molecular cancer therapeutics.

[26]  K. Helin,et al.  E2F target genes: unraveling the biology. , 2004, Trends in biochemical sciences.

[27]  A. Datta,et al.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. , 2004, Genes & development.

[28]  Robert H. Costa,et al.  Forkhead Box M1B Transcriptional Activity Requires Binding of Cdk-Cyclin Complexes for Phosphorylation-Dependent Recruitment of p300/CBP Coactivators , 2004, Molecular and Cellular Biology.

[29]  K. Shokat,et al.  Targets of the cyclin-dependent kinase Cdk1 , 2003, Nature.

[30]  Michael B. Yaffe,et al.  Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs , 2003, Nucleic Acids Res..

[31]  H. Kiyokawa,et al.  The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Gudkov,et al.  Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. , 2002, Genes & development.

[33]  M. Noble,et al.  Reversal of Growth Suppression by p107 via Direct Phosphorylation by Cyclin D1/Cyclin-Dependent Kinase 4 , 2002, Molecular and Cellular Biology.

[34]  M. Barbacid,et al.  Cyclin D-dependent kinases, INK4 inhibitors and cancer. , 2002, Biochimica et biophysica acta.

[35]  Yanhui Hu,et al.  Proteome-scale purification of human proteins from bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[37]  G. Peters,et al.  The p16INK4a/CDKN2A tumor suppressor and its relatives. , 1998, Biochimica et biophysica acta.

[38]  Zhou Songyang,et al.  Use of an oriented peptide library to determine the optimal substrates of protein kinases , 1994, Current Biology.